PET in Prostate and Bladder Tumors

Seminars in Nuclear Medicine, 06/08/2012

New positron emission tomography (PET) tracers are showing promise in the staging and biological characterization of prostate cancer, which can assist with therapeutic decision making in patients undergoing radiotherapy of primary disease, and in the assessment of metastatic disease.

Print Article Summary Cat 2 CME Report